Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2025-02-27
DOI
https://doi.org/10.1186/s12916-025-03964-9
Citations
6
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
11.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China

Zhongqiu Wang, Ximei Zhang, Qingxin Wang, Qi Wang et al.
6 citations
BMC Medicine
Head and Neck Cancer Studies
11.09
article

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China

Zhongqiu Wang, Ximei Zhang, Qingxin Wang, Qi Wang, Wei Wang, Jian Sun, Yao Sun, Yanlan Chai, Peiguo Wang
article en
6 citations

Abstract

No abstract available for this paper.
BMC MedicineVol. 23(1)
Tianjin Medical University Cancer Institute and Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 1%
Head and Neck Cancer Studies
11.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China — Zhongqiu Wang, Ximei Zhang, et al. · BMC Medicine (2025) | TGRS Research Map | TGRS